- Home
- RPTX vs TVGN Comparison
RPTX vs TVGN Comparison
Compare RPTX & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$2.57
Company Overview
Basic Information| Metric | RPTX | TVGN |
|---|---|---|
| Founded | 2016 | 2020 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 92.4M | 89.6M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | RPTX | TVGN |
|---|---|---|
| Price | $2.57 | $0.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $3.00 | ★ $5.00 |
| AVG Volume (30 Days) | 1.3M | ★ 1.4M |
| Earning Date | 11-14-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $11,870,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2,122.22 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.89 | $0.36 |
| 52 Week High | $2.66 | $1.92 |
Technical Indicators
Market Signals| Indicator | RPTX | TVGN |
|---|---|---|
| Relative Strength Index (RSI) | 74.94 | 40.64 |
| Support Level | $2.15 | $0.37 |
| Resistance Level | $2.66 | $0.41 |
| Average True Range (ATR) | 0.06 | 0.03 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 83.96 | 19.64 |
Price Performance
Historical Comparison RPTX
TVGN
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.
About TVGN Tevogen Bio Holdings Inc.
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.